vs
COASTAL FINANCIAL CORP（CCB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
COASTAL FINANCIAL CORP的季度营收约是RIGEL PHARMACEUTICALS INC的2.0倍（$138.0M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -5.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -3.6%）
富达国民金融是美国财富500强企业，面向房地产与按揭行业提供产权保险及交割服务。2019年，其产权及房地产业务相关年营收约为84.69亿美元，是行业内具有领先地位的金融服务提供商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CCB vs RIGL — 直观对比
营收规模更大
CCB
是对方的2.0倍
$69.8M
营收增速更快
RIGL
高出27.0%
-5.8%
两年增速更快
RIGL
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $138.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 12.4% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | -5.8% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.84 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCBRIGL
| Q4 25 | $138.0M | $69.8M | ||
| Q3 25 | $144.7M | $69.5M | ||
| Q2 25 | $119.4M | $101.7M | ||
| Q1 25 | $139.5M | $53.3M | ||
| Q4 24 | $146.5M | $57.6M | ||
| Q3 24 | $151.1M | $55.3M | ||
| Q2 24 | $135.3M | $36.8M | ||
| Q1 24 | $148.4M | $29.5M |
净利润CCBRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $13.6M | $27.9M | ||
| Q2 25 | $11.0M | $59.6M | ||
| Q1 25 | $9.7M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $13.5M | $12.4M | ||
| Q2 24 | $11.6M | $-1.0M | ||
| Q1 24 | $6.8M | $-8.2M |
毛利率CCBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CCBRIGL
| Q4 25 | 12.4% | 33.2% | ||
| Q3 25 | 12.4% | 40.9% | ||
| Q2 25 | 12.0% | 60.1% | ||
| Q1 25 | 8.4% | 23.9% | ||
| Q4 24 | 11.7% | 28.9% | ||
| Q3 24 | 10.8% | 25.4% | ||
| Q2 24 | 11.1% | 1.2% | ||
| Q1 24 | 5.9% | -23.6% |
净利率CCBRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 9.4% | 40.2% | ||
| Q2 25 | 9.2% | 58.6% | ||
| Q1 25 | 7.0% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 8.9% | 22.5% | ||
| Q2 24 | 8.6% | -2.8% | ||
| Q1 24 | 4.6% | -27.9% |
每股收益（稀释后）CCBRIGL
| Q4 25 | $0.84 | $14.11 | ||
| Q3 25 | $0.88 | $1.46 | ||
| Q2 25 | $0.71 | $3.28 | ||
| Q1 25 | $0.63 | $0.63 | ||
| Q4 24 | $0.95 | $0.82 | ||
| Q3 24 | $0.97 | $0.70 | ||
| Q2 24 | $0.84 | $-0.06 | ||
| Q1 24 | $0.50 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $491.0M | $391.5M |
| 总资产 | $4.7B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CCBRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务CCBRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CCBRIGL
| Q4 25 | $491.0M | $391.5M | ||
| Q3 25 | $475.3M | $117.6M | ||
| Q2 25 | $461.7M | $81.9M | ||
| Q1 25 | $449.9M | $18.6M | ||
| Q4 24 | $438.7M | $3.3M | ||
| Q3 24 | $331.9M | $-14.6M | ||
| Q2 24 | $316.7M | $-29.9M | ||
| Q1 24 | $303.7M | $-31.7M |
总资产CCBRIGL
| Q4 25 | $4.7B | $513.6M | ||
| Q3 25 | $4.6B | $242.5M | ||
| Q2 25 | $4.5B | $206.7M | ||
| Q1 25 | $4.3B | $176.0M | ||
| Q4 24 | $4.1B | $164.0M | ||
| Q3 24 | $4.1B | $139.4M | ||
| Q2 24 | $4.0B | $128.4M | ||
| Q1 24 | $3.9B | $126.5M |
负债/权益比CCBRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $254.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $246.1M | — |
| 自由现金流率自由现金流/营收 | 178.3% | — |
| 资本支出强度资本支出/营收 | 6.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $436.4M | — |
8季度趋势，按日历期对齐
经营现金流CCBRIGL
| Q4 25 | $254.6M | $22.0M | ||
| Q3 25 | $59.0M | $24.0M | ||
| Q2 25 | $66.0M | $30.5M | ||
| Q1 25 | $71.7M | $-893.0K | ||
| Q4 24 | $259.8M | $14.5M | ||
| Q3 24 | $62.6M | $21.7M | ||
| Q2 24 | $72.1M | $302.0K | ||
| Q1 24 | $56.8M | $-5.0M |
自由现金流CCBRIGL
| Q4 25 | $246.1M | — | ||
| Q3 25 | $57.4M | — | ||
| Q2 25 | $64.0M | — | ||
| Q1 25 | $68.9M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $60.2M | — | ||
| Q2 24 | $69.5M | — | ||
| Q1 24 | $55.0M | — |
自由现金流率CCBRIGL
| Q4 25 | 178.3% | — | ||
| Q3 25 | 39.7% | — | ||
| Q2 25 | 53.6% | — | ||
| Q1 25 | 49.4% | — | ||
| Q4 24 | 170.6% | — | ||
| Q3 24 | 39.8% | — | ||
| Q2 24 | 51.3% | — | ||
| Q1 24 | 37.1% | — |
资本支出强度CCBRIGL
| Q4 25 | 6.1% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 6.8% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 1.2% | — |
现金转化率CCBRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.34× | 0.86× | ||
| Q2 25 | 5.99× | 0.51× | ||
| Q1 25 | 7.37× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 4.65× | 1.75× | ||
| Q2 24 | 6.22× | — | ||
| Q1 24 | 8.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
RIGL
暂无分部数据
